Singapore, Sept. 24 -- UK-based eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Thailand's Siam Bioscience, a leading biopharmaceutical company in ASEAN, have announced a strategic partnership to build the region's foremost centre for Cell and Gene Therapy (CGT) development and manufacturing.

The collaboration aims to stimulate and accelerate the growth of the CGT industry in Thailand and Southeast Asia. It will provide a comprehensive suite of services to support local innovation and attract global therapies and investment into the region. Based in Bangkok, the new offering will serve therapy developers working to deliver advanced medicines to patients more efficiently and in full regula...